Indo-cyanine green (ICG) in paediatric oncology MIS

  • Research type

    Research Study

  • Full title

    An open label, single centre, single arm, prospective feasibility study evaluating the effectiveness of near-infrared fluorescence (NIRF) using indo-cyanine green (ICG) in intra-abdominal or intra-thoracic minimally invasive surgery (MIS) in paediatric oncology.

  • IRAS ID

    279548

  • Contact name

    Maximilian Pachl

  • Contact email

    Max.pachl@nhs.net

  • Sponsor organisation

    Birmingham Children's Hospital

  • Clinicaltrials.gov Identifier

    NCT04854018

  • Duration of Study in the UK

    1 years, 6 months, 1 days

  • Research summary

    An open label, single arm feasability study to evaluate if Near Infra-Red Fluorescence (NIRF) with Indo-Cyanine Green (ICG) enhances identification of lymph nodes in minimally invasive (keyhole/MIS) tumour nephrectomy in children and to assess whether fluorescing nodes are positive for disease following injection into tumour.
    The study will also evaluate if NIRF with ICG gives a better picture of tumour margins in keyhole removal of paediatric tumours namely rhabdomyosarcoma (RMS), Non-rhabdomyosarcomatous soft tissue tumour (NRSTS) resection or keyhole partial nephrectomy (NSS) following intravenous injection.
    Thirdly, the study will evaluate if NIRF with ICG improves the intra-operative detection rate during keyhole resection of lung metastases when compared to the number and location of lesions seen on cross-sectional imaging following intravenous injection.

    These are important topics to evaluate as they may reduce morbidity by using keyhole rather than open surgery. The children will receive standard oncology management and NIRF with ICG will be evaluated to ascertain if it can improve that standard management.

  • REC name

    West Midlands - South Birmingham Research Ethics Committee

  • REC reference

    20/WM/0261

  • Date of REC Opinion

    26 Nov 2020

  • REC opinion

    Further Information Favourable Opinion